« Back
Home /
Revusiran (sodium)

Revusiran (sodium)

Item no.	HY-132590A-5mg
Manufacturer	MedChem Express
Amount	5 mg
Quantity options	1 ea 10 mg 1 mg 5 mg
Specific against	other
Purity	93.16
Citations	[1]Jessica E Sutherland, et al. Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis. Nucleic Acid Ther. 2020 Feb;30(1):33-49.
Smiles	[Revusiran (sodium)]
Available
Product Description	Revusiran sodium is a 1st-generation short interfering RNA, which directed against transthyretin (TTR) mRNA. Revusiran sodium can be used for transthyretin (TTR)-mediated amyloidosis research[1].
StorageTemperature	-20°C (Powder, sealed storage, away from moisture)
Shipping	Blue Ice
Manufacturers Applications	Neuroscience-Neuromodulation
Clinical Information	No Development Reported
Manufacturers Research Area	Neurological Disease
Solubility	10 mM in H2O
Target	Small Interfering RNA (siRNA); Transthyretin (TTR)
Manufacturers Target	Small Interfering RNA (siRNA); Transthyretin (TTR)
Manufacturers Pathway	Epigenetics; Neuronal Signaling
Manufacturers Product type	Oligonucleotides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Request delivery time